Panacea Biotec trades jubilantly on getting USFDA’s approval for Rizatriptan Benzoate Tablet

18 Jan 2017 Evaluate

Panacea Biotec is currently trading at Rs. 142.60, up by 16.35 points or 12.95% from its previous closing of Rs. 126.25 on the BSE.

The scrip opened at Rs. 135.10 and has touched a high and low of Rs. 145.00 and Rs. 134.20 respectively. So far 157048 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 155.00 on 25-Jul-2016 and a 52 week low of Rs. 83.90 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 145.00 and Rs. 122.15 respectively. The current market cap of the company is Rs. 852.00 crore.

The promoters holding in the company stood at 74.60%, while institutions and non-institutions held 0.13% and 25.27% respectively.

Panacea Biotec has received approval from US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to market a generic version of Rizatriptan Benzoate Tablet, Orally Disintegrating, 5 mg and 10 mg.

This generic is equivalent to MAXALT-MLT ODT of Merck & Co. The current annual sales for Rizatriptan Benzoate Tablet, Orally Disintegrating, 5 mg and 10 mg in the US market is around $ 60 million. Rizatriptan Benzoate is a serotonin (5-HT) 1B/11) receptor against (triptan) indicated for the acute treatment of migraine in adults and in pediatric patients.

Further, the company is planning to launch the product within first quarter of 2017 through its distribution partner in US. Recently, the company got approval of its anti-cancer formulation facility from USFDA in November, 2016.

Panacea Biotec is one of the India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

344.65 -0.10 (-0.03%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×